1.Pelvic Drainage Following Radical Hysterectomy with Pelvic Lymphadenectomy for Cervical Cancer: Is it Necessary? .
Jin JEONG ; Kung Hun KIM ; Ho Sun CHOI
Korean Journal of Gynecologic Oncology and Colposcopy 1999;10(3):251-257
OBJECTIVES: This study was to determine whether drainage after radical hysterectomy and bilateral pelvic lymphadenectomy can reduce the risk of postoperative morbidity as compared with no drainage. METHODS: 165 patients with stage Ia2 to Ilb underwent radical hysterectomy and bilateral pelvic lymphadenectomy between January 1995 and May 1997, and those medical records were analyzed, Closed suction drains were placed in group I (n 102), not in group II (n 67). All surgeries were perforrned by the same surgeon in a uniform method. RESULTS: The characteristics of two groups were similar for mean age, preoperative weight, total protein, serum albumin, tumor cell histology, invasion depth, and tumor stage. There was no difference in mean operation time in two groups. But mean estimated blood loss was more in group I than group lI(p<0.05), Postoperative ileus and postoperative stay was similar in both groups. The incidence of pelvic lymphocyst and febrile morbidity in two groups were comparable with 17% in group I and 27% in poup II, but not statistically significant(p>0.05). Rehospitalization rate was higher in group I than in group II. CONCLUSION: Pelvic drainage didn't reduce the postoperative febrile morbidity and lymphocyst formation. Therefore the author could not find any necessity to perform the drainage following radical hysterectomy and pelvic lymphadenectomy.
Drainage*
;
Humans
;
Hysterectomy*
;
Ileus
;
Incidence
;
Lymph Node Excision*
;
Medical Records
;
Serum Albumin
;
Suction
;
Uterine Cervical Neoplasms*
2.Immediate oromandibular reconstruction by osteocutaneous free flap after composite resection.
Jang Su SUH ; Jin Kyu PARK ; Ywong Hun KWON ; Jae Sung CHOI ; Kyeong Jong CHOI
Korean Journal of Otolaryngology - Head and Neck Surgery 1993;36(4):758-765
No abstract available.
Free Tissue Flaps*
3.Surgical Results of Scleral Buckling without Subretinal Fluid Drainage in Patients with Primary Rhegmatogenous Retinal Detachment
Sung Uk HAN ; Hun Jin CHOI ; Ji Hun SONG
Journal of the Korean Ophthalmological Society 2020;61(11):1302-1310
Purpose:
To assess the clinical outcomes of scleral buckling (SB) without subretinal fluid drainage (SRFD) on primary rhegmatogenous retinal detachment (RRD).
Methods:
The medical records of patients with RRD treated via SB without SRFD from March 2009 to Feb 2018 were retrospectively reviewed. Cases with histories of previous intraocular surgery (except cataract removal) were excluded. The primary and final surgical success rates were the main outcome measures. Pre- and post-operative visual acuity and intraocular pressure (IOP), factors that might affect the surgical success rate, secondary operative procedures, re-operation rates, and complications were analyzed.
Results:
A total of 66 eyes of 66 patients were included. The mean patient age was 38.9 ± 18.6 years and the mean symptom duration 19.23 ± 25.14 days. The retinae were reattached after single surgeries on 57 eyes (success rate 86.36%); the final success rate was 100% after a second operation (when necessary). Of the nine eyes requiring additional surgery, seven required vitrectomy and two vitrectomy combined with buckle revision. The mean preoperative logMAR visual acuity of 0.578 ± 0.647 improved to 0.518 ± 0.512 at 1 month after surgery (p < 0.001) and to 0.262 ± 0.372 at the last follow-up visit (p < 0.001). The postoperative IOP was higher than the preoperative IOP at 3 months (p = 0.024).
Conclusions
Scleral buckling without SRFD used to treat primary RRD afforded a high reattachment rate (compared to those of previous reports employing vitrectomy or scleral buckling with SRFD). Given the possible complications of SRFD, our method may be a safe and feasible surgical option, affording good results with few complications in patients with primary RRD.
4.Surgical Results of Scleral Buckling without Subretinal Fluid Drainage in Patients with Primary Rhegmatogenous Retinal Detachment
Sung Uk HAN ; Hun Jin CHOI ; Ji Hun SONG
Journal of the Korean Ophthalmological Society 2020;61(11):1302-1310
Purpose:
To assess the clinical outcomes of scleral buckling (SB) without subretinal fluid drainage (SRFD) on primary rhegmatogenous retinal detachment (RRD).
Methods:
The medical records of patients with RRD treated via SB without SRFD from March 2009 to Feb 2018 were retrospectively reviewed. Cases with histories of previous intraocular surgery (except cataract removal) were excluded. The primary and final surgical success rates were the main outcome measures. Pre- and post-operative visual acuity and intraocular pressure (IOP), factors that might affect the surgical success rate, secondary operative procedures, re-operation rates, and complications were analyzed.
Results:
A total of 66 eyes of 66 patients were included. The mean patient age was 38.9 ± 18.6 years and the mean symptom duration 19.23 ± 25.14 days. The retinae were reattached after single surgeries on 57 eyes (success rate 86.36%); the final success rate was 100% after a second operation (when necessary). Of the nine eyes requiring additional surgery, seven required vitrectomy and two vitrectomy combined with buckle revision. The mean preoperative logMAR visual acuity of 0.578 ± 0.647 improved to 0.518 ± 0.512 at 1 month after surgery (p < 0.001) and to 0.262 ± 0.372 at the last follow-up visit (p < 0.001). The postoperative IOP was higher than the preoperative IOP at 3 months (p = 0.024).
Conclusions
Scleral buckling without SRFD used to treat primary RRD afforded a high reattachment rate (compared to those of previous reports employing vitrectomy or scleral buckling with SRFD). Given the possible complications of SRFD, our method may be a safe and feasible surgical option, affording good results with few complications in patients with primary RRD.
5.Comparison of Clinical Result of LASIK using between Femtosecond Laser and Microkeratome for Correction of Myopia.
Yun Su CHOI ; Hee Jin JUNG ; Kyung Hun LEE
Journal of the Korean Ophthalmological Society 2007;48(8):1041-1047
PURPOSE: To compare results between in femtosecond laser and microkeratome LASIK correction of myopia METHODS: We retrospectively analyzed the result of 94 eyes of 47 patients in the femtosecond group (F) and 103 eyes of 52 patients in the microkeratome group (M). All patients had undergone LASIK using either a femtosecond laser or a microkeratome for making of flap. Patients were divided into groups I (6D< or =) and II (> or =6D) according to preoperative myopia. Each patient was followed up for over 6 months with measurements of uncorrected visual acuity and manifest refraction at 1 week and 1, 3, and 6 months after operation. Complications during and after the operation were reviewed retrospectively in two groups 6month after the operation. RESULTS: In groups F-I, F-II, M-I, and M-II, postoperative 6-month uncorrected visual acuity was 0.98+/-0.08, 0.96+/-0.09, 0.97+/-0.03, 0.98+/-0.09. At the 6-month follow-up, there were no significant differences between the two groups in uncorrected visual acuity and mean spherical equivalent. Corneal opacity was found in 3 eyes in group M and complication related with flap was found 1 eye in group F and 4 eyes in group M. CONCLUSIONS: During a 6-month follow up, LASIK using either a femtosecond laser or a microkeratome has an similar effect in uncorrected visual acuity and mean spherical equivalent. Thus LASIK for using femtosecond laser can be used as an alternative procedure to correct myopia.
Corneal Opacity
;
Follow-Up Studies
;
Humans
;
Keratomileusis, Laser In Situ*
;
Myopia*
;
Retrospective Studies
;
Visual Acuity
6.Prognostic Significance COX-2, VEGF and Cyclin D1 in Distant Metastasis of Breast Cancer.
Journal of Breast Cancer 2007;10(1):10-18
PURPOSE: The most important independent prognostic factors of breast cancer have been reported to the tumor size and lymph node metastasis, as well as DNA ploidy, proliferation index, and various receptors, including estrogen receptor (ER) and progesteron receptor (PR) and oncogenes, such as c-erbB-2, and the tumor suppressor gene, p53. However, all these prognostic factors are still unable to exactly estimate distant metastasis for breast cancer. Based on this, our aim was to study for the prognostic factors that associated distant metastasis of breast cancer with cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF), which are related to angiogenesis, and Cyclin D1, which participates in cell proliferation in breast cancer. METHODS: A retrospective study was carried out on 95 patients, who has undergone an operation for breast cancer, with or without metastasis between January 1993 and July 2001, at the Department of Surgery, Chungnam National University Hospital. The study was based on the immunohistochemical staining of primary tumors for COX-2, VEGF, Cyclin D1, ER, PR and c-erbB-2, which were obtained from tissue samples of 45 and 50 patients with and with no distant metastatic breast cancer. SPSS for Windows, Version 10.0 was used for the statistical analyses. RESULTS: The expressions of COX-2, VEGF and Cyclin D1 were statistically significant in distant metastatic breast cancer. The clinicopathological parameters associated with distant metastasis were the tumor size and histological grade, and lymph node metastasis, lymphovascular invasion, ER and PR. There were positive correlations between 1) COX-2 and VEGF, 2) COX-2 and Cyclin D1, 3) c-erbB-2 and Cyclin D1 and 4) VEGF and Cyclin D1, COX-2 also had positive relationships with the tumor size and c-erbB-2, VEGF had positive relationships with lymph node metastasis, histological grade and lymphovascular invasion, as well as with ER and PR. The overexpressions of COX-2, VEGF and Cyclin D1 shortened the disease-free survival and survival period. CONCLUSION: The overexpressions of COX-2, VEGF and Cyclin D1 were considered poor prognostic factors for the induction of distant metastasis. Therefore, COX-2, VEGF and Cyclin D1 could be used in the prevention of distant metastasis, and prescribed for the treatment of metastatic breast cancer.
Breast Neoplasms*
;
Breast*
;
Cell Proliferation
;
Chungcheongnam-do
;
Cyclin D1*
;
Cyclins*
;
Cyclooxygenase 2
;
Disease-Free Survival
;
DNA
;
Estrogens
;
Genes, Tumor Suppressor
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis*
;
Oncogenes
;
Ploidies
;
Retrospective Studies
;
Vascular Endothelial Growth Factor A*
7.The change of indications for cesarean section for recent 20 years.
Young Chul CHOI ; Dong Ho KIM ; Dong Jin KIM ; Dae Hwa KIM ; Hun Jung IM
Korean Journal of Obstetrics and Gynecology 1993;36(7):2561-2570
No abstract available.
Cesarean Section*
;
Female
;
Pregnancy
8.Expression of Met Protein in Colorectal Carcinoma.
Kyung Un CHOI ; Jin Sook LEE ; Chang Hun LEE ; Mee Young SOL ; Kang Suk SUH
Korean Journal of Pathology 2000;34(7):501-508
Met protein is a transmembrane 190 kD heterodimer with tyrosine kinase activity, encoded by c-Met oncogene. It serves as a high affinity receptor for hepatocyte growth factor (HGF)/scatter factor (SF), a cytokine which stimulates cell proliferation, motility, and invasion. In this study, we immunohistochemically evaluated the expression of Met/hepatocyte growth factor receptor in colorectal cancers. Met protein was expressed in 31 of 72 patients (43.1%). The staining pattern was cytoplasmic in nature, present throughout the tumor, and showed variable intensity from case to case. The relationship between the expression rate and intensity, and age and sex of patients, tumor size (p=0.645), tumor site (p=0.902) and tumor differentiation (p=0.844) was not statistically significant. The expression rate and intensity were significantly correlated with lymphovascular invasion (p=0.001), lymph node metastasis (p=0.010), depth of invasion (0.019), and stage (p=0.023). Cytoplasmic accumulation of Met protein was not associated with enhanced PCNA index of tumor cells (p=0.052). These results suggest that Met protein may play an important role in the invasion and metastasis of colorectal cancer cells.
Cell Proliferation
;
Colorectal Neoplasms*
;
Cytoplasm
;
Hepatocyte Growth Factor
;
Humans
;
Lymph Nodes
;
Neoplasm Metastasis
;
Oncogenes
;
Proliferating Cell Nuclear Antigen
;
Protein-Tyrosine Kinases
9.One case of hereditary spherocytosis with aplastic crisis.
Kee Young PARK ; Ho Kyung CHOI ; Jong Jin SEO ; Keon Su RHEE ; Yong Hun CHUNG
Journal of the Korean Pediatric Society 1991;34(6):843-848
No abstract available.
10.A clinical study of Graves' disease in children.
Kee Young PARK ; Ho Kyung CHOI ; Jong Jin SEO ; Young Hun CHUNG
Journal of the Korean Pediatric Society 1991;34(6):812-819
No abstract available.
Child*
;
Graves Disease*
;
Humans